We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH/GSK Ebola Vaccine Trial Shows Positive Results
Phase III trials of two Ebola vaccines will kick off in the next few weeks in Liberia, according to the National Institute of Allergy and Infectious Diseases.